全文获取类型
收费全文 | 27958篇 |
免费 | 2440篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 238篇 |
儿科学 | 1008篇 |
妇产科学 | 860篇 |
基础医学 | 3978篇 |
口腔科学 | 467篇 |
临床医学 | 3652篇 |
内科学 | 5129篇 |
皮肤病学 | 394篇 |
神经病学 | 3116篇 |
特种医学 | 521篇 |
外科学 | 2669篇 |
综合类 | 439篇 |
一般理论 | 46篇 |
预防医学 | 3574篇 |
眼科学 | 562篇 |
药学 | 1826篇 |
中国医学 | 32篇 |
肿瘤学 | 1940篇 |
出版年
2023年 | 210篇 |
2022年 | 220篇 |
2021年 | 581篇 |
2020年 | 404篇 |
2019年 | 632篇 |
2018年 | 692篇 |
2017年 | 555篇 |
2016年 | 573篇 |
2015年 | 655篇 |
2014年 | 924篇 |
2013年 | 1309篇 |
2012年 | 1956篇 |
2011年 | 1973篇 |
2010年 | 1069篇 |
2009年 | 1008篇 |
2008年 | 1626篇 |
2007年 | 1813篇 |
2006年 | 1749篇 |
2005年 | 1635篇 |
2004年 | 1608篇 |
2003年 | 1475篇 |
2002年 | 1359篇 |
2001年 | 397篇 |
2000年 | 343篇 |
1999年 | 357篇 |
1998年 | 297篇 |
1997年 | 262篇 |
1996年 | 198篇 |
1995年 | 180篇 |
1994年 | 156篇 |
1993年 | 181篇 |
1992年 | 236篇 |
1991年 | 238篇 |
1990年 | 224篇 |
1989年 | 221篇 |
1988年 | 206篇 |
1987年 | 178篇 |
1986年 | 188篇 |
1985年 | 185篇 |
1984年 | 168篇 |
1983年 | 195篇 |
1982年 | 134篇 |
1981年 | 110篇 |
1980年 | 125篇 |
1979年 | 128篇 |
1978年 | 108篇 |
1977年 | 88篇 |
1976年 | 99篇 |
1974年 | 107篇 |
1973年 | 98篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Shylo R. Johnson Dennis Slate Kathleen M. Nelson Amy J. Davis Samual A. Mills John T. Forbes Kurt C. VerCauteren Amy T. Gilbert Richard B. Chipman 《Viruses》2021,13(2)
Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the westward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination of raccoon RV from the eastern USA has proven challenging across targeted raccoon (Procyon lotor) and striped skunk (Mephitis mephitis) populations impacted by raccoon RV. Field trial evaluations of the Ontario Rabies Vaccine Bait (ONRAB) were initiated to expand ORV products available to meet the rabies management goal of raccoon RV elimination. This study describes the continuation of a 2011 trial in West Virginia. Our objective was to evaluate raccoon and skunk response to ORV occurring in West Virginia for an additional two years (2012–2013) at 75 baits/km2 followed by three years (2014–2016) of evaluation at 300 baits/km2. We measured the change in rabies virus-neutralizing antibody (RVNA) seroprevalence in targeted wildlife populations by comparing levels pre- and post-ORV during each year of study. The increase in bait density from 75/km2 to 300/km2 corresponded to an increase in average post-ORV seroprevalence for raccoon and skunk populations. Raccoon population RVNA levels increased from 53% (300/565, 95% CI: 50–57%) to 82.0% (596/727, 95% CI: 79–85%) during this study, and skunk population RVNA levels increased from 11% (8/72, 95% CI: 6–20%) to 39% (51/130, 95% CI: 31–48%). The RVNA seroprevalence pre-ORV demonstrated an increasing trend across study years for both bait densities and species, indicating that multiple years of ORV may be necessary to achieve and maintain RVNA seroprevalence in target wildlife populations for the control and elimination of raccoon RV in the eastern USA. 相似文献
5.
6.
7.
Sameer Arora Kamal Shemisa Muthiah Vaduganathan Arman Qamar Ankur Gupta Sushil K. Garg Dharam J. Kumbhani Helen Mayo Houman Khalili Ambarish Pandey Sandeep R. Das 《Journal of the American College of Cardiology》2019,73(19):2454-2464
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects such as bleeding and dyspnea have been associated with premature ticagrelor discontinuation, which may limit any potential advantage of ticagrelor over clopidogrel. The randomized trials of ticagrelor captured adverse events, offering the opportunity to more precisely quantify these effects across studies. Therefore, a meta-analysis of 4 randomized clinical trials of ticagrelor conducted between January 2007 and June 2017 was performed to quantify the incidence and causes of premature ticagrelor discontinuation. Among 66,870 patients followed for a median 18 months, premature ticagrelor discontinuation was seen in 25%; bleeding was the most common cause of discontinuation followed by dyspnea. Versus the comparators, the relative risk of dyspnea-related discontinuation during follow-up was 6.4-fold higher, the relative risk of bleeding was 3.2-fold higher, and the relative risk of discontinuation due to any adverse event was 59% higher for patients receiving ticagrelor. Understanding these potential barriers to adherence to ticagrelor is crucial for informed patient-physician decision making and can inform future efforts to improve ticagrelor adherence. This review discusses the incidence, causes, and biological mechanisms of ticagrelor-related adverse effects and offers strategies to improve adherence to ticagrelor. 相似文献
8.
Mary Ann Richardson Helen M Chao Laura L Read James D Clelland Raymond F Suckow 《American journal of medical genetics. Part B, Neuropsychiatric genetics》2006,(2):195-197
Phenylketonuria (PKU), an inborn error of phenylalanine metabolism, has been shown to be a risk factor for tardive dyskinesia (TD). In male psychiatric patients there was a significant relationship between TD and measures of plasma phenylalanine following ingestion of a standardized phenylalanine dose that was indicative of higher brain availability of phenylalanine in patients with TD. In addition, a medical food formulation consisting of branched chain amino acids, which compete with phenylalanine for transport across the blood-brain barrier, has been demonstrated to be an efficacious treatment for TD. Cumulatively these findings suggested that TD was related to phenylalanine metabolism and thus that sequence variants in the gene for phenylalanine hydroxylase (PAH), the rate-limiting enzyme in the catabolism of phenylalanine, could be associated with TD susceptibility. Genetic screening of PAH in a group of 123 psychiatric patients revealed ten sequence polymorphisms and two mutations, but none appeared to be a significant risk factor for TD. 相似文献
9.
10.